Health and Fitness Health and Fitness
Mon, January 12, 2009
[ Mon, Jan 12th 2009 ] - Market Wire
Vertex Outlines 2009 Business Priorities: Registr .. and Cystic Fibrosis; Balanced Investment to Main
[ Mon, Jan 12th 2009 ] - Market Wire
Covalon Technologies Ltd.: Covalon Welcomes New Board Member
[ Mon, Jan 12th 2009 ] - Market Wire
EnteroMedics Announces Eighteen-Month Excess Weig .. Loss Results from its VBLOC-RF2 Feasibility Study
[ Mon, Jan 12th 2009 ] - Market Wire
Qnexa Treatment Results in Improved Glucose Control in Obese Non-Diabetic Subjects
[ Mon, Jan 12th 2009 ] - Market Wire
ARYx Therapeutics, Inc. Provides Additional Data on Atrial Fibrillation Clinical Trial on ATI-2042
[ Mon, Jan 12th 2009 ] - Market Wire
VIVUS Announces Issuance of Key European Patent for Qnexa"
[ Mon, Jan 12th 2009 ] - Market Wire
Cytori Forms Commercialization Partnership with GE Healthcare
[ Mon, Jan 12th 2009 ] - Market Wire
Kenneth I. Shine to Join UnitedHealth Group Board of Directors
[ Mon, Jan 12th 2009 ] - Market Wire
Acorda Therapeutics Provides 2009 Business and Pi .. ate at 27th Annual JPMorgan Healthcare Conference
[ Mon, Jan 12th 2009 ] - Market Wire
Soliris(R) Receives Orphan Drug Designation in Japan
[ Mon, Jan 12th 2009 ] - Market Wire
Cubist Pharmaceuticals Announces Full Year 2008 Total Net Revenues of $433.6 Million
[ Mon, Jan 12th 2009 ] - Market Wire
Illumina Genome Analyzer Selected by Internationa .. nized Medical Center to Sequence 50 Human Genomes
Sun, January 11, 2009
[ Sun, Jan 11th 2009 ] - Market Wire
FORTIS: Fortis holding organises Extraordinary General Meetings of Shareholders
[ Sun, Jan 11th 2009 ] - Market Wire
Medtronic to Acquire Ablation Frontiers
[ Sun, Jan 11th 2009 ] - Market Wire
Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement
Fri, January 9, 2009
[ Fri, Jan 09th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics to Present at the 27th Annual JPMorgan Healthcare Conference
[ Fri, Jan 09th 2009 ] - Market Wire
Arbios Announces It Has Voluntarily Filed for Chapter 11 Bankruptcy Protection
[ Fri, Jan 09th 2009 ] - Market Wire
Northfield Laboratories Inc. Reports Fiscal 2009 Second Quarter Financial Results
[ Fri, Jan 09th 2009 ] - Market Wire
Biodel Inc. to Present at 27th Annual JPMorgan Healthcare Conference on January 15th, 2009
[ Fri, Jan 09th 2009 ] - Market Wire
St. Jude Medical Announces Fourth Quarter and Full-Year 2008 Earnings Conference Call
[ Fri, Jan 09th 2009 ] - Market Wire
Coventry Health Care to Speak at the J.P. Morgan Healthcare Conference
[ Fri, Jan 09th 2009 ] - Market Wire
Alphatec Spine to Hold 2009 Revenue and Earnings Guidance Investor Call
[ Fri, Jan 09th 2009 ] - Market Wire
Medtronic CEO William Hawkins to Speak at 27th Annual JP Morgan Healthcare Conference
[ Fri, Jan 09th 2009 ] - Market Wire
Sequenom Proposes to Acquire EXACT Sciences for $1.50 Per Share or Approximately $41 Million
[ Fri, Jan 09th 2009 ] - Market Wire
MedaSorb Technologies Corporation: MedaSorb Technologies Corporation Announces Management Changes
[ Fri, Jan 09th 2009 ] - Market Wire
SCOR: SCOR comments on decision of the Swiss Fede .. l Administrative Tribunal dated December 22, 2008
[ Fri, Jan 09th 2009 ] - Market Wire
HearUSA: HearUSA Reports Revenues for Fourth Quarter 2008
[ Fri, Jan 09th 2009 ] - Market Wire
Helicos BioSciences to Present at JPMorgan Healthcare Conference on Thursday, January 15, 2009
[ Fri, Jan 09th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences' Transcatheter Valve Patent Found Valid in UK Court
[ Fri, Jan 09th 2009 ] - Market Wire
Biogen Idec to Report Fourth Quarter and Full Year 2008 Financial Results on February 6, 2009

Biogen Idec to Report Fourth Quarter and Full Year 2008 Financial Results on February 6, 2009


Published on 2009-01-09 09:21:30, Last Modified on 2009-01-09 09:21:52 - Market Wire
  Print publication without navigation


CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report fourth quarter and full year 2008 financial results on Friday, February 6, 2009 before the financial markets open.

Following the release of the financials, the Company will host a live webcast where Biogen Idec management will discuss the financial results, at 8:30 am ET. To access the live webcast, please go to Biogen Idec's website at [ http://investor.biogenidec.com/ ]. Following the live webcast, an archived version of the call will be available at the same URL, for one month.

About Biogen Idec

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources